Correlation of host factor with virological response to direct-acting antiviral treatment in hepatitis C patients

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2090-6226
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Correlation of host factor with virological response to direct-acting antiviral treatment in hepatitis C patients ; volume:12 ; number:1 ; day:9 ; month:9 ; year:2022 ; pages:1-7 ; date:12.2022
Egyptian liver journal ; 12, Heft 1 (9.9.2022), 1-7, 12.2022

Urheber
Rusman, Resha Dermawansyah
Daud, Nu’man AS
Parewangi, Muhammad Luthfi
Bakri, Syakib
Aman, Andi Makbul
Rasyid, Haerani
Seweng, Arifin
Tahir, Akiko Syawalidhany
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s43066-022-00217-9
URN
urn:nbn:de:101:1-2022120409023765045145
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:21 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Rusman, Resha Dermawansyah
  • Daud, Nu’man AS
  • Parewangi, Muhammad Luthfi
  • Bakri, Syakib
  • Aman, Andi Makbul
  • Rasyid, Haerani
  • Seweng, Arifin
  • Tahir, Akiko Syawalidhany
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection

Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)

Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report

Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C

Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents

Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents

Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents

Verbundene Objekte